Brian C. Mac Grory

Preprint · February 20, 2026 BACKGROUND AND AIMS: The glucagon-like peptide-1 receptor agonist (GLP-1 RA) semaglutide has demonstrated efficacy for the secondary prevention of cardiovascular disease among patients with overweight/obesity without diabetes mellitus. However, the compara ... Full text Link to item Cite

Uptake and Safety Profile of Anti-Amyloid Immunotherapies in Routine Clinical Practice

Preprint · 2025 Full text Cite

Door-in-Door-Out Times at Referring Hospitals and Outcomes from Hemorrhagic Stroke

Preprint · 2024 Full text Cite

Intracerebral Hemorrhage Outcomes after Reversal of Subtherapeutic Warfarin: Analysis of Data from GWTG-Stroke

Preprint · 2024 Full text Cite

Statin Therapy in Ischemic Stroke Patients with Atrial Fibrillation: Efficacy and Safety Outcomes

Preprint · 2024 Background The efficacy and safety of statins for secondary prevention in patients who have experienced a cardioembolic stroke are not well-defined. However, previous observational data reported hyperlipidemia as a risk factor for both ischemic an ... Full text Cite

Predictors of Stroke Recurrence After Initial Diagnosis of Cervical Artery Dissection

Preprint · 2024 Full text Cite

Performance of Thrombectomy-Capable, Comprehensive, and Primary Stroke Centers in Reperfusion Therapies for Acute Ischemic Stroke: Report from the Get With The Guidelines Stroke Registry: Stroke Outcomes Per Hospital Certification Status.

Preprint · July 6, 2023 Full text Link to item Cite

COVID-19 Infection Is Associated with Poor Outcomes in Patients with Intracerebral Hemorrhage

Preprint · 2023 ABSTRACTBackground Patients with ischemic stroke and concomitant coronavirus 2019 (COVID-19) infection have worse outcomes than those without this infection. However, research on the impact of COVID-19 infection on outcomes following hem ... Full text Cite